Erratum: Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation (Neuropsychopharmacology (2006) 31, (2505-2513) DOI: 10.1038/sj.npp.1301113)

Mark Hyman Rapaport, Georges M. Gharabawi, Carla M. Canuso, Ramy A. Mahmoud, Martin B. Keller, Cynthia A. Bossie, Ibrahim Turkoz, Robert A. Lasser, Amy Loescher, Philippe Bouhours, Fiona Dunbar, Charles Nemeroff

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
JournalNeuropsychopharmacology
Volume32
Issue number5
DOIs
StatePublished - May 24 2007
Externally publishedYes

Fingerprint

Treatment-Resistant Depressive Disorder
Risperidone
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Erratum : Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation (Neuropsychopharmacology (2006) 31, (2505-2513) DOI: 10.1038/sj.npp.1301113). / Rapaport, Mark Hyman; Gharabawi, Georges M.; Canuso, Carla M.; Mahmoud, Ramy A.; Keller, Martin B.; Bossie, Cynthia A.; Turkoz, Ibrahim; Lasser, Robert A.; Loescher, Amy; Bouhours, Philippe; Dunbar, Fiona; Nemeroff, Charles.

In: Neuropsychopharmacology, Vol. 32, No. 5, 24.05.2007.

Research output: Contribution to journalArticle

Rapaport, Mark Hyman ; Gharabawi, Georges M. ; Canuso, Carla M. ; Mahmoud, Ramy A. ; Keller, Martin B. ; Bossie, Cynthia A. ; Turkoz, Ibrahim ; Lasser, Robert A. ; Loescher, Amy ; Bouhours, Philippe ; Dunbar, Fiona ; Nemeroff, Charles. / Erratum : Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation (Neuropsychopharmacology (2006) 31, (2505-2513) DOI: 10.1038/sj.npp.1301113). In: Neuropsychopharmacology. 2007 ; Vol. 32, No. 5.
@article{6fa6857138af486cbdda5020f8cc1ad2,
title = "Erratum: Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation (Neuropsychopharmacology (2006) 31, (2505-2513) DOI: 10.1038/sj.npp.1301113)",
author = "Rapaport, {Mark Hyman} and Gharabawi, {Georges M.} and Canuso, {Carla M.} and Mahmoud, {Ramy A.} and Keller, {Martin B.} and Bossie, {Cynthia A.} and Ibrahim Turkoz and Lasser, {Robert A.} and Amy Loescher and Philippe Bouhours and Fiona Dunbar and Charles Nemeroff",
year = "2007",
month = "5",
day = "24",
doi = "10.1038/sj.npp.1301322",
language = "English",
volume = "32",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Erratum

T2 - Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation (Neuropsychopharmacology (2006) 31, (2505-2513) DOI: 10.1038/sj.npp.1301113)

AU - Rapaport, Mark Hyman

AU - Gharabawi, Georges M.

AU - Canuso, Carla M.

AU - Mahmoud, Ramy A.

AU - Keller, Martin B.

AU - Bossie, Cynthia A.

AU - Turkoz, Ibrahim

AU - Lasser, Robert A.

AU - Loescher, Amy

AU - Bouhours, Philippe

AU - Dunbar, Fiona

AU - Nemeroff, Charles

PY - 2007/5/24

Y1 - 2007/5/24

UR - http://www.scopus.com/inward/record.url?scp=34247403052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247403052&partnerID=8YFLogxK

U2 - 10.1038/sj.npp.1301322

DO - 10.1038/sj.npp.1301322

M3 - Article

AN - SCOPUS:34247403052

VL - 32

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 5

ER -